Next generation therapeutics for Alzheimer's disease
Abstract To date, no truly effective therapy has been developed for Alzheimer's disease or mild cognitive impairment. In searching for new approaches that may succeed where previous ones have failed, it may be instructive to consider the successful therapeutic developments for other chronic ill...
Main Authors: | Dale E. Bredesen, Varghese John |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
Springer Nature
2013-05-01
|
סדרה: | EMBO Molecular Medicine |
נושאים: | |
גישה מקוונת: | https://doi.org/10.1002/emmm.201202307 |
פריטים דומים
-
Potential Antioxidant Multitherapy against Complications Occurring in Sepsis
מאת: Joaquin Abelli, et al.
יצא לאור: (2022-12-01) -
Emerging advances in fluorescence imaging and phototherapy of arthritis
מאת: Xiaoxuan Wang, et al.
יצא לאור: (2023-11-01) -
Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives
מאת: María Gabriela Montiel Schneider, et al.
יצא לאור: (2022-01-01) -
Editorial: Highlights in Alzheimer's and Parkinson's disease
מאת: Mariagiovanna Cantone, et al.
יצא לאור: (2023-08-01) -
Insights from Turkey's big data: unraveling the preventability, pathogenesis, and risk management of Alzheimer's disease (AD)
מאת: Talip Yiğit, et al.
יצא לאור: (2024-03-01)